[
  {
    "ts": null,
    "headline": "FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health",
    "summary": "RAHWAY, N.J., July 10, 2025--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) approval of BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) – a new, once-yearly1 injectable product to treat and protect dogs from fleas and ticks. The product is expected to be available at veterinary clinics and hospitals nationwi",
    "url": "https://finnhub.io/api/news?id=60b013b0fc58d2187022a6c233f9465838760b3ad180e4366c856126fb122dd8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752180300,
      "headline": "FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health",
      "id": 135866664,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., July 10, 2025--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) approval of BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) – a new, once-yearly1 injectable product to treat and protect dogs from fleas and ticks. The product is expected to be available at veterinary clinics and hospitals nationwi",
      "url": "https://finnhub.io/api/news?id=60b013b0fc58d2187022a6c233f9465838760b3ad180e4366c856126fb122dd8"
    }
  },
  {
    "ts": null,
    "headline": "Pod Digital Media Celebrates Seven Years of Connecting Brands Authentically to Growth Audiences",
    "summary": "NEW YORK, July 10, 2025--Pod Digital Media (PDM), the cultural hub for growth audiences, podcasts, influencers, live events and activations, announced today its seventh anniversary. For seven years, PDM has been at the forefront of connecting blue-chip advertisers with the consumer segments that command nearly five-trillion-dollar in buying power.",
    "url": "https://finnhub.io/api/news?id=96edd7a3342e6b970012b4cc0127b3052d95629857bfc5980feee9a27f3c7b91",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752173940,
      "headline": "Pod Digital Media Celebrates Seven Years of Connecting Brands Authentically to Growth Audiences",
      "id": 135863147,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "NEW YORK, July 10, 2025--Pod Digital Media (PDM), the cultural hub for growth audiences, podcasts, influencers, live events and activations, announced today its seventh anniversary. For seven years, PDM has been at the forefront of connecting blue-chip advertisers with the consumer segments that command nearly five-trillion-dollar in buying power.",
      "url": "https://finnhub.io/api/news?id=96edd7a3342e6b970012b4cc0127b3052d95629857bfc5980feee9a27f3c7b91"
    }
  },
  {
    "ts": null,
    "headline": "Veteran analyst sends bold message on Palantir stock target",
    "summary": "Here’s what could be next for Palantir.",
    "url": "https://finnhub.io/api/news?id=aa564e2ae8ef56679fb3fb87b11e3810376b477293002fba9bcb609f1bde0e20",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752169620,
      "headline": "Veteran analyst sends bold message on Palantir stock target",
      "id": 135866581,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Here’s what could be next for Palantir.",
      "url": "https://finnhub.io/api/news?id=aa564e2ae8ef56679fb3fb87b11e3810376b477293002fba9bcb609f1bde0e20"
    }
  },
  {
    "ts": null,
    "headline": "Merck Animal Health's Flea-and-Tick Treatment Approved in U.S.",
    "summary": "By Katherine Hamilton Merck's animal health division received Food and Drug Administration approval for its once-yearly injectable flea-and-tick treatment for dogs. Merck Animal Health said...",
    "url": "https://finnhub.io/api/news?id=60e7315626127991d8b9c561aa509da047448f70d61f87b410dd665a66da802c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752167589,
      "headline": "Merck Animal Health's Flea-and-Tick Treatment Approved in U.S.",
      "id": 135862462,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "By Katherine Hamilton Merck's animal health division received Food and Drug Administration approval for its once-yearly injectable flea-and-tick treatment for dogs. Merck Animal Health said...",
      "url": "https://finnhub.io/api/news?id=60e7315626127991d8b9c561aa509da047448f70d61f87b410dd665a66da802c"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge Appreciation Strategy Q2 2025 Commentary",
    "summary": "The ClearBridge Appreciation Strategy underperformed the benchmark S&P 500 Index in the second quarter. On an absolute basis, the Strategy had gains in seven of 11 sectors.",
    "url": "https://finnhub.io/api/news?id=36b49fe24baf46d3641aa0635fc34d4f91dea6a18c599a0c0333ca041eeee170",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752163620,
      "headline": "ClearBridge Appreciation Strategy Q2 2025 Commentary",
      "id": 135862073,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1645710848/image_1645710848.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "The ClearBridge Appreciation Strategy underperformed the benchmark S&P 500 Index in the second quarter. On an absolute basis, the Strategy had gains in seven of 11 sectors.",
      "url": "https://finnhub.io/api/news?id=36b49fe24baf46d3641aa0635fc34d4f91dea6a18c599a0c0333ca041eeee170"
    }
  },
  {
    "ts": null,
    "headline": "Alcohol Related Liver Disease Market Forecast, 2025-2035 | Personalized Medicine Transforming ARLD Treatment Landscape",
    "summary": "The Global Alcohol-Related Liver Disease Market report for 2025-2035 highlights the escalating trend of alcohol-related liver conditions like alcoholic fatty liver disease (AFLD), alcoholic hepatitis, fibrosis, and cirrhosis, driven by rising alcohol consumption. Key players including Merck, Pfizer, and Novartis are innovating treatments and diagnostics to combat these diseases. Early detection advances and personalized medicine are boosting market growth. Despite challenges like late diagnosis",
    "url": "https://finnhub.io/api/news?id=fc574c7cf7eadc46a9410c55e36b866d579c7fb966dbf816ed8e4a52fd4fc525",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752155220,
      "headline": "Alcohol Related Liver Disease Market Forecast, 2025-2035 | Personalized Medicine Transforming ARLD Treatment Landscape",
      "id": 135855970,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The Global Alcohol-Related Liver Disease Market report for 2025-2035 highlights the escalating trend of alcohol-related liver conditions like alcoholic fatty liver disease (AFLD), alcoholic hepatitis, fibrosis, and cirrhosis, driven by rising alcohol consumption. Key players including Merck, Pfizer, and Novartis are innovating treatments and diagnostics to combat these diseases. Early detection advances and personalized medicine are boosting market growth. Despite challenges like late diagnosis",
      "url": "https://finnhub.io/api/news?id=fc574c7cf7eadc46a9410c55e36b866d579c7fb966dbf816ed8e4a52fd4fc525"
    }
  },
  {
    "ts": null,
    "headline": "Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck",
    "summary": "Verona Pharma plc (NASDAQ:VRNA) is one of the 10 Stocks Going Wild. Verona Pharma surged by 20.62 percent on Wednesday to end at $104.77 per share following news that it was being acquired by US-based pharmaceutical company Merck for $10 billion. In a statement, Merck said that it entered into a definitive agreement with Verona Pharma […]",
    "url": "https://finnhub.io/api/news?id=bdd4883a2b63ee986468b43ade213775a8ddc4d1ce3453f99f784b4e5d2ee949",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752151837,
      "headline": "Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck",
      "id": 135851013,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Verona Pharma plc (NASDAQ:VRNA) is one of the 10 Stocks Going Wild. Verona Pharma surged by 20.62 percent on Wednesday to end at $104.77 per share following news that it was being acquired by US-based pharmaceutical company Merck for $10 billion. In a statement, Merck said that it entered into a definitive agreement with Verona Pharma […]",
      "url": "https://finnhub.io/api/news?id=bdd4883a2b63ee986468b43ade213775a8ddc4d1ce3453f99f784b4e5d2ee949"
    }
  },
  {
    "ts": null,
    "headline": "Fda approves Bravecto Quantum, a long-acting injectable for dogs 6 months and older",
    "summary": "July 10 - FDA: approves Bravecto Quantum , for use in dogs and puppies 6 months of age and older...",
    "url": "https://finnhub.io/api/news?id=aaaec03eb192f1d52c561c2e99320293143407d52ca8791ab0fa603a2ad1a6ab",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752148450,
      "headline": "Fda approves Bravecto Quantum, a long-acting injectable for dogs 6 months and older",
      "id": 135854750,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "July 10 - FDA: approves Bravecto Quantum , for use in dogs and puppies 6 months of age and older...",
      "url": "https://finnhub.io/api/news?id=aaaec03eb192f1d52c561c2e99320293143407d52ca8791ab0fa603a2ad1a6ab"
    }
  },
  {
    "ts": null,
    "headline": "Trump Says Powell’s Fed Job Is Easy. Why Nvidia, Bitcoin, Market Rally Say Otherwise and 5 Other Things to Know Today.",
    "summary": "Federal Reserve officials split over when to cut rates, Brazil vows response to 50% tariff, and more news to start your day.",
    "url": "https://finnhub.io/api/news?id=e849e0d25ccc50a6b8a5ff8e291c3eb91d8c33bacc53d45473e0864b99be5010",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752145140,
      "headline": "Trump Says Powell’s Fed Job Is Easy. Why Nvidia, Bitcoin, Market Rally Say Otherwise and 5 Other Things to Know Today.",
      "id": 135850179,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Federal Reserve officials split over when to cut rates, Brazil vows response to 50% tariff, and more news to start your day.",
      "url": "https://finnhub.io/api/news?id=e849e0d25ccc50a6b8a5ff8e291c3eb91d8c33bacc53d45473e0864b99be5010"
    }
  },
  {
    "ts": null,
    "headline": "These Are The Most Overvalued And Undervalued Mega Cap Stocks",
    "summary": "These Are The Most Overvalued And Undervalued Mega Cap Stocks",
    "url": "https://finnhub.io/api/news?id=5d1188996de610d85b617148b91a54f4e10a95dc28b96e263ef778afb7ab47a9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752144489,
      "headline": "These Are The Most Overvalued And Undervalued Mega Cap Stocks",
      "id": 135853176,
      "image": "",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=5d1188996de610d85b617148b91a54f4e10a95dc28b96e263ef778afb7ab47a9"
    }
  },
  {
    "ts": null,
    "headline": "U.S. FDA Accepts New Drug Application for Merck’s Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection",
    "summary": "RAHWAY, N.J., July 10, 2025--U.S. FDA Accepts New Drug Application for Merck’s DOR/ISL Once-Daily Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1.",
    "url": "https://finnhub.io/api/news?id=1762b9004290c02c8bb7f1edcebd3f3ee4f34612e1d14692c75f1ab6575cb12d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752144300,
      "headline": "U.S. FDA Accepts New Drug Application for Merck’s Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection",
      "id": 135855977,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., July 10, 2025--U.S. FDA Accepts New Drug Application for Merck’s DOR/ISL Once-Daily Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1.",
      "url": "https://finnhub.io/api/news?id=1762b9004290c02c8bb7f1edcebd3f3ee4f34612e1d14692c75f1ab6575cb12d"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals: My Highest Conviction Pharma Pick For 2025",
    "summary": "Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN stock is upgraded to buy.",
    "url": "https://finnhub.io/api/news?id=2495b4aff067e964fa9334b784dd6c51873da2d471928bb2c9a40098efee24f3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752138900,
      "headline": "Regeneron Pharmaceuticals: My Highest Conviction Pharma Pick For 2025",
      "id": 135851366,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1336356688/image_1336356688.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN stock is upgraded to buy.",
      "url": "https://finnhub.io/api/news?id=2495b4aff067e964fa9334b784dd6c51873da2d471928bb2c9a40098efee24f3"
    }
  },
  {
    "ts": null,
    "headline": "Merck agrees to acquire Verona Pharma for $10bn",
    "summary": "The transaction will enhance Merck's cardio-pulmonary pipeline and portfolio with the addition of Ohtuvayre, an FDA-approved COPD treatment.",
    "url": "https://finnhub.io/api/news?id=0514ab1cab2eac87d3141cacbb039e13cac6e8f4c25a37dfa75ff05024159c96",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752137863,
      "headline": "Merck agrees to acquire Verona Pharma for $10bn",
      "id": 135855979,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The transaction will enhance Merck's cardio-pulmonary pipeline and portfolio with the addition of Ohtuvayre, an FDA-approved COPD treatment.",
      "url": "https://finnhub.io/api/news?id=0514ab1cab2eac87d3141cacbb039e13cac6e8f4c25a37dfa75ff05024159c96"
    }
  },
  {
    "ts": null,
    "headline": "Zacks Investment Ideas feature highlights: QQQ, IWM, SBET, CRCL, COIN, AES, MRK and VRNA",
    "summary": "QQQ hits its longest streak above the 10-day average in 2025, even as overbought signals and tariff jitters stir caution.",
    "url": "https://finnhub.io/api/news?id=03133dbc776051c4c5116642fbe10c4a7d015188d823a3869416cee5e2171210",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752134640,
      "headline": "Zacks Investment Ideas feature highlights: QQQ, IWM, SBET, CRCL, COIN, AES, MRK and VRNA",
      "id": 135848441,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "QQQ hits its longest streak above the 10-day average in 2025, even as overbought signals and tariff jitters stir caution.",
      "url": "https://finnhub.io/api/news?id=03133dbc776051c4c5116642fbe10c4a7d015188d823a3869416cee5e2171210"
    }
  },
  {
    "ts": null,
    "headline": "U.S. FDA Accepts New Drug Application for Merck's Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection",
    "summary": "Merck announced that the U.S. Food and Drug Administration has accepted for review the New Drug Application for doravirine/islatravir , an investigational, once-daily, oral, two-drug regimen for...",
    "url": "https://finnhub.io/api/news?id=f372ae509eae450fbf998ffa3faffad40af717d6ba0e550d524fd89178b55481",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752133842,
      "headline": "U.S. FDA Accepts New Drug Application for Merck's Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection",
      "id": 135848997,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Merck announced that the U.S. Food and Drug Administration has accepted for review the New Drug Application for doravirine/islatravir , an investigational, once-daily, oral, two-drug regimen for...",
      "url": "https://finnhub.io/api/news?id=f372ae509eae450fbf998ffa3faffad40af717d6ba0e550d524fd89178b55481"
    }
  },
  {
    "ts": null,
    "headline": "Merck : FDA to Review Doravirine/Islatravir Regimen in HIV-1 Infection",
    "summary": "By Colin Kellaher Merck & Co. said the U.S. Food and Drug Administration will review its application seeking approval of its proposed doravirine/islatravir regimen in certain adults with HIV-1...",
    "url": "https://finnhub.io/api/news?id=fbeeff38914911a37805de593865d9fc6cf5d53295ecbd2bc52cad9a7b0f76e8",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752132137,
      "headline": "Merck : FDA to Review Doravirine/Islatravir Regimen in HIV-1 Infection",
      "id": 135848384,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "By Colin Kellaher Merck & Co. said the U.S. Food and Drug Administration will review its application seeking approval of its proposed doravirine/islatravir regimen in certain adults with HIV-1...",
      "url": "https://finnhub.io/api/news?id=fbeeff38914911a37805de593865d9fc6cf5d53295ecbd2bc52cad9a7b0f76e8"
    }
  },
  {
    "ts": null,
    "headline": "Merck: FDA to Review Doravirine/Islatravir Regimen in HIV-1 Infection",
    "summary": "Merck: FDA to Review Doravirine/Islatravir Regimen in HIV-1 Infection",
    "url": "https://finnhub.io/api/news?id=aee45364083f54252249d2352072b26960279733de313a6e45a92c5899add500",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752131160,
      "headline": "Merck: FDA to Review Doravirine/Islatravir Regimen in HIV-1 Infection",
      "id": 135859324,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck: FDA to Review Doravirine/Islatravir Regimen in HIV-1 Infection",
      "url": "https://finnhub.io/api/news?id=aee45364083f54252249d2352072b26960279733de313a6e45a92c5899add500"
    }
  },
  {
    "ts": null,
    "headline": "U.S. FDA accepts new drug application for Merck's doravirine/islatravir",
    "summary": "Merck & Co Inc: U.S. FDA accepts new drug application for Merck's doravirine/islatravir, an investigational, once-daily, oral, two-drug regimen for treatment of adults with virologically...",
    "url": "https://finnhub.io/api/news?id=913e01039fc7103d72657e9ee27670094e4bf020c74ec43d7b659425447aa475",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752130450,
      "headline": "U.S. FDA accepts new drug application for Merck's doravirine/islatravir",
      "id": 135847682,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Merck & Co Inc: U.S. FDA accepts new drug application for Merck's doravirine/islatravir, an investigational, once-daily, oral, two-drug regimen for treatment of adults with virologically...",
      "url": "https://finnhub.io/api/news?id=913e01039fc7103d72657e9ee27670094e4bf020c74ec43d7b659425447aa475"
    }
  },
  {
    "ts": null,
    "headline": "Deals of the day-Mergers and acquisitions",
    "summary": "The following bids, mergers,acquisitions and disposals were reported by 0930 GMT onThursday: ** Blackstone said it had raised its offer to buyWarehouse REIT to 115 pence per share,...",
    "url": "https://finnhub.io/api/news?id=c443aa485b498b203f0c8ccb3a6d3ff9a9693495897852b42b2d49dac67ae6fb",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752126494,
      "headline": "Deals of the day-Mergers and acquisitions",
      "id": 135846223,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "The following bids, mergers,acquisitions and disposals were reported by 0930 GMT onThursday: ** Blackstone said it had raised its offer to buyWarehouse REIT to 115 pence per share,...",
      "url": "https://finnhub.io/api/news?id=c443aa485b498b203f0c8ccb3a6d3ff9a9693495897852b42b2d49dac67ae6fb"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co snaps up respiratory drug maker Verona for USD10 billion",
    "summary": "Merck & Co Inc on Wednesday said it has struck a deal to acquire Verona Pharma PLC, bolstering its respiratory diseases offering. Merck will fork out USD107 per American depository share in Verona,...",
    "url": "https://finnhub.io/api/news?id=7caf9e7e0dce60de99d5a5d1d7d9906a7f4c59d4b6b01d8410979a4bbab866d0",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752120488,
      "headline": "Merck & Co snaps up respiratory drug maker Verona for USD10 billion",
      "id": 135844092,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Merck & Co Inc on Wednesday said it has struck a deal to acquire Verona Pharma PLC, bolstering its respiratory diseases offering. Merck will fork out USD107 per American depository share in Verona,...",
      "url": "https://finnhub.io/api/news?id=7caf9e7e0dce60de99d5a5d1d7d9906a7f4c59d4b6b01d8410979a4bbab866d0"
    }
  }
]